Skip to main content
. 2014 Sep;12(5):418–426. doi: 10.1370/afm.1691

Table 3.

Multivariate Analysis of Patient and Clinician Factors That Influenced IPHR Use

Variable Adjusted OR (95% CI)
Patient age 1.01 (1.01–1.01)
Patient sex (female vs male) 1.09 (1.03–1.15)
Patient race
 Asian vs white 1.18 (1.09–1.27)
 Black vs white 0.89 (0.80–0.98)
 Hispanic vs white 0.36 (0.18–0.73)
 Other vs white 0.75 (0.58–0.96)
Patient’s comorbidities (none vs any) 0.67 (0.63–0.71)
Clinician sex (female vs male) 1.37 (1.26–1.49)
Clinician age, y
 25–34 vs 35–54 0.72 (0.66–0.80)
 55+ vs 35–54 0.63 (0.55–0.72)
Clinician, resident status
 Nonresident vs resident 0.96 (0.86–1.08)
Clinician: early adoptera
 Agree vs disagree 1.58 (1.44–1.73)
 Neither vs disagree 1.27 (1.16–1.38)
Clinician: trainingb
 Agree vs disagree 1.41 (1.29–1.54)
 Neither vs disagree 0.84 (0.76–0.94)
Clinician: confidencec
 Agree vs disagree 1.96 (1.75–2.19)
 Neither vs disagree 0.83 (0.75–0.92)

IPHR = interactive prevention health record; OR = odds ratio.

Notes: Values adjusted for patient and clinician characteristics, as well as practice. Only statistically significant variables were included in the final multivariate analyses.

a

“Among my colleagues, I am usually one of the first to find out about a new test or treatment (strongly agree) (agree) (neither agree nor disagree) (disagree) (strongly disagree).” Reported by clinicians 1 year after fielding the IPHR.

b

“The training I received about MyPreventiveCare was adequate (strongly agree) (agree) (neither agree nor disagree) (disagree) (strongly disagree).” Reported by clinicians 1 year after fielding the IPHR.

c

“I feel confident in my ability to use MyPreventiveCare (strongly agree) (agree) (neither agree nor disagree) (disagree) (strongly disagree).” Reported by clinicians 1 year after fielding the IPHR.